An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer

被引:43
|
作者
Shui, Ruohong [1 ,2 ]
Yu, Baohua [1 ,2 ]
Bi, Rui [1 ,2 ]
Yang, Fei [1 ,2 ]
Yang, Wentao [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 05期
关键词
LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER;
D O I
10.1371/journal.pone.0125131
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Ki67 in breast cancer: a useful prognostic marker?
    Caldarella, A.
    Crocetti, E.
    Paci, E.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 542 - 542
  • [42] Improvement of Ki67 Staining in Breast Cancer (BC)
    Muftah, A. A.
    Aleskandarany, M.
    Al-Kaabi, M. M.
    Jerjees, D. A.
    Abduljabbar, R. F.
    Alsubhi, N. H.
    Ellis, I. O.
    Rakha, E. A.
    Green, A. R.
    JOURNAL OF PATHOLOGY, 2015, 237 : S30 - S30
  • [43] KI67 Expression in Primary Male Breast Cancer
    Erices-Leclercq, Melanie
    Rudlowski, Christian
    Baldus, Stephan
    Foerster, Frank
    Schroeder, Lars
    Stiller, Franziska
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 27 - 28
  • [44] Interlaboratory variability of Ki67 staining in breast cancer
    Focke, Cornelia M.
    Buerger, Horst
    van Diest, Paul J.
    Finsterbusch, Kai
    Glaeser, Doreen
    Korsching, Eberhard
    Decker, Thomas
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 219 - 227
  • [45] Interobserver Variability of Ki-67 Measurement in Breast Cancer
    Chung, Yul Ri
    Jang, Min Hye
    Park, So Yeon
    Gong, Gyungyub
    Jung, Woo-Hee
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (02) : 129 - 137
  • [46] Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
    Hida, Akira I.
    Bando, Kenji
    Sugita, Atsuro
    Maeda, Toshiharu
    Ueda, Norifumi
    Matsukage, Shoichi
    Nakanishi, Mamoru
    Kito, Katsumi
    Miyazaki, Tatsuhiko
    Ohtsuki, Yuji
    Oshiro, Yumi
    Inoue, Hiromichi
    Kawaguchi, Hidetoshi
    Yamashita, Natsumi
    Aogi, Kenjiro
    Moriya, Takuya
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (05) : 356 - 361
  • [47] Does a Standardized Protocol for Measuring Ki67 Improve Interobserver Variability in Breast Carcinoma?
    Ordobazari, A.
    Stone, J.
    Hunt, B.
    Behmaram, B.
    MODERN PATHOLOGY, 2014, 27 : 72A - 73A
  • [48] Does a Standardized Protocol for Measuring Ki67 Improve Interobserver Variability in Breast Carcinoma?
    Ordobazari, A.
    Stone, J.
    Hunt, B.
    Behmaram, B.
    LABORATORY INVESTIGATION, 2014, 94 : 72A - 73A
  • [49] Number Needed To Count: A Novel Model for Ki67 Assessment in Breast Cancer.
    Bendahl, P-O
    Romero, Q.
    Grabau, D.
    Borgquist, S.
    CANCER RESEARCH, 2011, 71
  • [50] Ki67 in early breast cancer: a retrospective analysis of 233 symptomatic patients
    Jones, O. P.
    Srivastava, V.
    Cochrane, R. A.
    Gate, T.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 103 - 104